ScreenerStandardsToolsLearnAbout

Screener / Biological Products, (No Diagnostic Substances) / Adaptive Biotechnologies Corp

ADPT · NASDAQ

Adaptive Biotechnologies Corp

Not compliant

Based on its latest SEC filing, measured against total assets, Adaptive Biotechnologies Corp is not compliant. In its latest filing, cash and short-term investments are 53.7% of total assets, above the limit.

TickerADPT
ExchangeNASDAQ
SectorBiological Products, (No Diagnostic Substances)
Not compliantAdaptive Biotechnologies CorpADPT · NASDAQ
PassBusiness activity
permissible core business
0.0%Interest income / revenue
limit 5%
0.0%Debt / total assets
limit 33.33%
53.7%Cash / total assets
limit 33.33%

Ratios from company filings.

Calculated by Purindex from Adaptive Biotechnologies Corp’s latest 10-Q filed with the SEC on 4 Aug 2026. Debt and cash are measured against total assets, as in the MSCI Islamic method, and the result above comes from these three ratios. AAOIFI measures against market cap instead, so its result can differ.

Interest-bearing debt / total assets
Short- and long-term borrowings on 30 Jun 2026
0.0%limit 33.33%Compliant
Cash and short-term investments / total assets
Cash, cash equivalents and short-term securities on 30 Jun 2026
53.7%limit 33.33%Not compliant
Interest income / revenue
6 months to 30 Jun 2026, no interest income line reported. Approximates impure revenue; other non-compliant income is not broken out in filings.
0.0%limit 5%Compliant

Source: SEC EDGAR filings. Market-cap based ratios (AAOIFI, S&P, Dow Jones) need share prices and are not shown yet.

Data and sources.

ResultCalculated by Purindex from the company's SEC filing (below).
Financial ratiosSEC 10-Q filed 4 Aug 2026, balance sheet at 30 Jun 2026. Market-cap ratios need share prices and are not shown yet.
MethodTotal-assets limits (MSCI-style): debt and cash below 33.33%, interest income below 5% of revenue. The AAOIFI market-cap test follows once share prices are loaded. Purindex method v1 · how it works
Last updated4 Nov 2026

Spotted a mistake? Report a data issue. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Adaptive Biotechnologies Corp or any other security.

Questions about Adaptive Biotechnologies Corp.

Is Adaptive Biotechnologies Corp (ADPT) stock halal?
Based on its latest SEC filing, measured against total assets, Adaptive Biotechnologies Corp is not compliant. In its latest filing, cash and short-term investments are 53.7% of total assets, above the limit.
How does Purindex decide whether ADPT is Shariah compliant?
The core business must be permissible, impure revenue must stay below 5% of total revenue, and interest-bearing debt and interest-bearing cash must each stay below 30% of market capitalisation. A company within 10% of a limit is marked doubtful. Until share prices are loaded, US, European and UK companies are checked against total assets (33.33% limits) using their official filings, and companies without verified data are marked insufficient data.
Should I buy Adaptive Biotechnologies Corp shares?
Purindex does not recommend buying, selling or holding Adaptive Biotechnologies Corp or any other security. It publishes screening information so you can check what you own. For a personal ruling, consult a qualified scholar.